Ortho Clinical Diagnostics nayo yatangije ibipimo bya mbere bya COVID-19 IgG spike antibody na test ya antibody ya nucleocapsid

Ortho Clinical Diagnostics, imwe mu masosiyete akomeye ku isi mu masosiyete asuzumisha vitro, yatangaje ko hatangijwe ikizamini cya mbere cya COVID-19 IgG antibody ndetse n’ikizamini cyuzuye cya antibody ya nucleocapsid ya COVID-19.
Ortho nisosiyete yonyine muri Reta zunzubumwe zunzubumwe zamerika itanga uruhurirane rwo gupima ingano no gupima nucleocapsid kuri laboratoire.Ibi bizamini byombi bifasha itsinda ryubuvuzi gutandukanya icyateye antibodies zirwanya SARS-CoV-2 no kuzitunganya kuri sisitemu ya VITROS® yizewe ya Ortho.
Ivan Sargo, MD, Ortho Clinical Diagnostics, ukuriye ubuvuzi, amavuriro n'ubumenyi, yagize ati: "Muri Amerika, inkingo zose zakingiwe zagenewe gutanga ibisubizo bya antibody kuri poroteyine ya virusi ya SARS-CoV-2"."Ikizamini gishya cya antibody ya Ortho, hamwe na test ya antibody nshya ya nucleocapsid, irashobora gutanga amakuru yinyongera kugirango ifashe kumenya niba igisubizo cya antibody gituruka ku kwandura bisanzwe cyangwa urukingo rwibasiwe na poroteyine." 1
Ikizamini cya VITROS® ya Ortho Anti-SARS-CoV-2 IgG ni cyo gipimo cya antibody cyo mu bwoko bwa IgG ni cyo kizamini cya mbere cya antibody muri Amerika gitanga indangagaciro zahinduwe hakurikijwe amahame mpuzamahanga y’ubuzima ku isi (OMS).Ikizamini gisanzwe cya antibody igereranya ifasha guhuza uburyo bwa SARS-CoV- 2 bwa serologiya kandi butanga igereranya ryamakuru muri laboratoire.Aya makuru ahuriweho nintambwe yambere yo gusobanukirwa izamuka nigabanuka rya antibodi kugiti cye ningaruka ndende z'icyorezo cya COVID-19 ku baturage no muri rusange.
Ikizamini gishya cya Ortho cyapimwe cyateguwe kugirango gipime ubuziranenge no kugereranya antibodiyite za IgG zirwanya SARS-CoV-2 muri serumu yumuntu na plasma, hamwe nibisobanuro 100% kandi bifite sensibilité nziza.3
Ortho nshya ya VITROS® Anti-SARS-CoV-2 Ikizamini cya Antibody Nucleocapsid Yuzuye ni ikizamini 4 cyuzuye cyo kumenya neza nucleocapsid ya SARS-CoV-2 ku barwayi banduye virusi ya SARS-CoV-2 Antibody.
Dr. Chockalingam Palaniappan yagize ati: "Buri gihe duhora twiga ubumenyi bushya kuri virusi ya SARS-CoV-2, kandi Ortho yiyemeje guha laboratoire ibisubizo nyabyo kugira ngo bibafashe guhangana n'ibibazo biriho ndetse n'ibizaza muri iki cyorezo gikomeje." , Umuyobozi mukuru ushinzwe guhanga udushya twa Ortho Clinical Diagnostics.
Ikizamini cya antibody ya COVID-19 ya Ortho cyasoje ikigo cy’Amerika gishinzwe ibiryo n’ibiyobyabwenge (FDA) cyo kumenyesha ibyihutirwa (EUN) ku ya 19 Gicurasi 2021, maze gitanga uruhushya rwo gukoresha byihutirwa (EUA) kugira ngo bipimishe FDA.Ikizamini cyayo cya VITROS® Anti-SARS-CoV-2 yipimishije antibody ya nucleocapsid yose yarangije gahunda ya EUN ku ya 5 Gicurasi 2021, inatanga EUA.
Urashaka kohereza amakuru yubumenyi agezweho muri inbox yawe?Ba umunyamuryango wa SelectScience ubu kubuntu >>
1. Abarwayi bakingiwe inkingo za virusi zidakora bazakora antibodiyite zirwanya N na anti-S.2. https://www.uwowe Days Nyuma yiminsi 15 ibimenyetso bitangiye


Igihe cyo kohereza: Jun-22-2021